載入...
Pre-clinical drug-drug interaction (DDI) of gefitinib or erlotinib with Cytochrome P450 (CYP) inhibiting drugs, fluoxetine and/or losartan
OBJECTIVE: To evaluate drug-drug interactions (DDIs) between gefitinib or erlotinib with fluoxetine, and/or losartan. METHODS: Human pooled microsomes, supersomes, and cryopreserved human hepatocytes were used to monitor DDIs in vitro. RED (Rapid Equilibrium Dialysis) protein binding was employed to...
Na minha lista:
| 發表在: | Curr Res Toxicol |
|---|---|
| Main Authors: | , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Elsevier
2021
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8320603/ https://ncbi.nlm.nih.gov/pubmed/34345864 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.crtox.2021.05.006 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|